Nuveen Asset Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $628K | Hold |
27,482
| – | – | ﹤0.01% | 2902 |
|
|
2024
Q3 | $1.15M | Hold |
27,482
| – | – | ﹤0.01% | 2693 |
|
|
2024
Q2 | $1M | Buy |
+27,482
| New | +$1M | ﹤0.01% | 2729 |
|
|
2022
Q2 | – | Sell |
-6,533
| Closed | -$252K | – | 3345 |
|
|
2022
Q1 | $252K | Buy |
6,533
+74
| +1% | +$2.85K | ﹤0.01% | 3150 |
|
|
2021
Q4 | $614K | Sell |
6,459
-547
| -8% | -$52K | ﹤0.01% | 3013 |
|
|
2021
Q3 | $1.16M | Sell |
7,006
-32
| -0.5% | -$5.28K | ﹤0.01% | 2940 |
|
|
2021
Q2 | $1.3M | Sell |
7,038
-56
| -0.8% | -$10.3K | ﹤0.01% | 2902 |
|
|
2021
Q1 | $1.75M | Sell |
7,094
-7,948
| -53% | -$1.96M | ﹤0.01% | 2681 |
|
|
2020
Q4 | $4.24M | Sell |
15,042
-269
| -2% | -$75.9K | ﹤0.01% | 2160 |
|
|
2020
Q3 | $3.68M | Buy |
15,311
+4,896
| +47% | +$1.18M | ﹤0.01% | 2079 |
|
|
2020
Q2 | $3.46M | Buy |
+10,415
| New | +$3.46M | ﹤0.01% | 2088 |
|